RETHINKING the ANALYSIS
JPEO-CBD takes a fresh look at the required analysis of alternatives and finds ways to make it a more ef fective, less time-consuming tool.
by Ms. Breena Berté and Mr. Marshall Kindred A
recent study by the Joint Program Executive Office for Chemical and Bio- logical Defense (JPEO-CBD) showed that the analyses of alternatives (AoAs)
conducted within the Chemical Biological Defense Program (CBDP) listed, on average, 23 measures of effectiveness and 72 measures of performance to be considered before milestone A. Te AoA is an essential and required step in establishing the most operationally suitable, cost-effective options to provide a needed, potentially joint capability. But, JPEO-CBD found, attempting to analyze the possible trades among that many factors required significant time and effort without improved results.
In particular, the study concluded that AoAs were taking about 18 months in attempts to collect and analyze an average of 72 measures of performance (MOPs) on every available technology, when, in the end, the JPEO found that it could not collect all
those data points. Even after investing the time and resources to collect the necessary data, there were significant gaps in the available information on the cost, schedule and performance of viable alternatives. And because there was no prioritizing of MOPs, the process failed to provide the milestone deci- sion authority (MDA) the information it needed to direct the program toward the most advantageous alternatives.
To move toward an AoA process more attuned to the needs of individual programs, JPEO-CBD is leading an effort across the CBDP to streamline the AoA process for Acquisition Category (ACAT) II and ACAT III programs. Te goal is a streamlined, tailored
approach that
ers and the MDA the precise information needed to make decisions early in the program’s life cycle while minimizing wasted time and effort. To this end, the JPEO-CBD has pinpointed areas in the
offers program manag-
ASC.ARMY.MIL
43
ACQUISITION
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170 |
Page 171 |
Page 172 |
Page 173 |
Page 174 |
Page 175 |
Page 176
